Technische Universität Dresden

This study compares two chemotherapy drugs, treosulfan and melphalan, given before a stem cell transplant in people with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). About 220 adults whose cancer is in remission or stable will take part. The goal is to see whic…

This study tests whether adding a new drug called obrixtamig to standard chemotherapy can help people with advanced large-cell neuroendocrine carcinoma of the lung, a rare and aggressive cancer. About 75 adults who have already started one round of chemo will receive the combinat…

This study creates a registry of 500 adults with myelodysplastic syndromes (MDS) or related conditions. Researchers will collect medical data and blood or bone marrow samples over time to track how these diseases progress. The goal is to better understand these rare blood disorde…

This study will collect and analyze tumor samples from 500 people with advanced non-small cell lung cancer to see how immune markers and gene activity relate to treatment response. Participants give biopsies before and during immunochemotherapy. The goal is to learn, not to test …